Key result
Prompt BiPAP and IV nitroglycerin rapidly resolve symptoms in sympathetic crashing acute pulmonary edema.
Why the study?
SCAPE is an acute emergency heart failure syndrome triggered by sympathetic overflow and underlying conditions such as valvular heart disease, requiring early identification and urgent management to reduce invasive ventilation and hospitalization.
Case Report (n=1)
Urgent SCAPE recognition needed in elderly valvular patients; leaves open prospective trials on management protocols.
Sympathetic crashing acute pulmonary edema (SCAPE) is an acute decompensated heart failure due to sympathetic overflow. SCAPE is usually triggered by acute insults with an underlying substrate such as long-standing hypertension, chronic heart failure, and valvular heart disease. We present a case of SCAPE in a 91-year-old female due to underlying multivalvular heart disease. Because of severe acute presentation, SCAPE should be identified early, and management should be urgently done to decrease the need for invasive ventilation and prolonged hospitalization.
No takes yet. Share an insight, caveat, or question.
Ashok et al. (2022) conducted a case report in Sympathetic Crashing Acute Pulmonary Edema (SCAPE) (n=1). BiPAP and intravenous nitroglycerin was evaluated on Symptom resolution. Prompt administration of BiPAP and intravenous nitroglycerin led to rapid symptom improvement in a patient presenting with sympathetic crashing acute pulmonary edema.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: